Clinical profile of patients with type 2 diabetes after COVID-19 vaccination: A prospective study

The purpose of this study was to characterize the clinical profile of patients with type 2 diabetes after COVID-19 vaccination. This prospective study has involved 100 adult diabetic patients followed in the primary health care. SARS-CoV-2 infection after COVID-19 vaccination was the outcome indicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrondo, Maria Cristina, Moita, Joaquim Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561417/
https://www.ncbi.nlm.nih.gov/pubmed/36268222
http://dx.doi.org/10.1016/j.obmed.2022.100458
_version_ 1784807947801460736
author Carrondo, Maria Cristina
Moita, Joaquim Jorge
author_facet Carrondo, Maria Cristina
Moita, Joaquim Jorge
author_sort Carrondo, Maria Cristina
collection PubMed
description The purpose of this study was to characterize the clinical profile of patients with type 2 diabetes after COVID-19 vaccination. This prospective study has involved 100 adult diabetic patients followed in the primary health care. SARS-CoV-2 infection after COVID-19 vaccination was the outcome indicator.
format Online
Article
Text
id pubmed-9561417
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-95614172022-10-16 Clinical profile of patients with type 2 diabetes after COVID-19 vaccination: A prospective study Carrondo, Maria Cristina Moita, Joaquim Jorge Obes Med Article The purpose of this study was to characterize the clinical profile of patients with type 2 diabetes after COVID-19 vaccination. This prospective study has involved 100 adult diabetic patients followed in the primary health care. SARS-CoV-2 infection after COVID-19 vaccination was the outcome indicator. The Authors. Published by Elsevier Ltd. 2022-10 2022-10-14 /pmc/articles/PMC9561417/ /pubmed/36268222 http://dx.doi.org/10.1016/j.obmed.2022.100458 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Carrondo, Maria Cristina
Moita, Joaquim Jorge
Clinical profile of patients with type 2 diabetes after COVID-19 vaccination: A prospective study
title Clinical profile of patients with type 2 diabetes after COVID-19 vaccination: A prospective study
title_full Clinical profile of patients with type 2 diabetes after COVID-19 vaccination: A prospective study
title_fullStr Clinical profile of patients with type 2 diabetes after COVID-19 vaccination: A prospective study
title_full_unstemmed Clinical profile of patients with type 2 diabetes after COVID-19 vaccination: A prospective study
title_short Clinical profile of patients with type 2 diabetes after COVID-19 vaccination: A prospective study
title_sort clinical profile of patients with type 2 diabetes after covid-19 vaccination: a prospective study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561417/
https://www.ncbi.nlm.nih.gov/pubmed/36268222
http://dx.doi.org/10.1016/j.obmed.2022.100458
work_keys_str_mv AT carrondomariacristina clinicalprofileofpatientswithtype2diabetesaftercovid19vaccinationaprospectivestudy
AT moitajoaquimjorge clinicalprofileofpatientswithtype2diabetesaftercovid19vaccinationaprospectivestudy

Ejemplares similares